Reumatologia 60(4):242-246, 2022
Direct and Indirect Effects of GLP-1 and GIP Receptor Agonism in the Human Body 2,4,5,12 In addition to their beneficial actions in diabetes and obesity, new research suggests that incretin-based therapies may reduce inflammation in the heart, liver, kidneys, and brain
This would have important implications for dietary quality across consumer groups
Balancing the Gut-Brain Axis There is also emerging interest in how BPC-157 interacts with the nervous system
At 8 mg per week, participants experienced substantial body weight reductions, positioning this level as a potentially optimal therapeutic target
Any appetite-related changes are secondary: as sleep improves, energy returns, and body composition shifts, patients naturally feel more motivated to support those changes with better nutrition